Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04104581 · ClinicalTrials.gov registry record · NA
Measuring Daily Grain Intake Study
A NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT04104581: Completed NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
NCT04104581 is a NA study that has completed, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04104581, a NA study, has completed, sponsored by USDA Beltsville Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The primary objective of this study is to identify markers of daily whole grain oat and whole grain wheat intake in humans.
Primary Outcome
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Interventions
- OTHER Control Refined Grain Diet
- OTHER Low Whole Grain Oat Diet
- OTHER High Whole Grain Oat Diet
- OTHER Low Whole Grain Wheat Diet
- OTHER High Whole Grain Wheat Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2019-08-04 |
| Est. Completion | 2020-03-16 |
| Phase | NA |
What the finished NCT04104581 record still lists
NCT04104581 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Control Refined Grain Diet is the first listed.
NCT04104581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04104581 about?
NCT04104581 is a clinical study titled "Measuring Daily Grain Intake Study". The primary objective of this study is to identify markers of daily whole grain oat and whole grain wheat intake in humans.
What is the current status of trial NCT04104581?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2019-08-04. Estimated completion is 2020-03-16.
What interventions are being tested in trial NCT04104581?
The interventions under investigation include: Control Refined Grain Diet (OTHER), Low Whole Grain Oat Diet (OTHER), High Whole Grain Oat Diet (OTHER), Low Whole Grain Wheat Diet (OTHER), High Whole Grain Wheat Diet (OTHER).
Who is sponsoring clinical trial NCT04104581?
This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04104581's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI